Hospital
Coffeyville Regional Medical Center, INC.
Coffeyville Regional Medical Center, INC. was paid $764K by Medicaid between Jan 2018 and Nov 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoCOFFEYVILLE REGIONAL MEDICAL CENTER, INC.
COFFEYVILLE, KS 67337
COFFEYVILLE, KS 67337
33aNPI1285600379assigned 02/27/2006
33bProvider typeRural Acute Care Hospital
28Total paid$764K
24GClaims42,805
24DCodes billed98
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Kansas
Rank by total paid#1 of 7
Median peer was paid$93K
This provider vs. median8.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,493 | $146K | |
| 2019 | 5,188 | $77K | |
| 2020 | 5,659 | $99K | |
| 2021 | 4,968 | $97K | |
| 2022 | 5,982 | $123K | |
| 2023 | 6,709 | $122K | |
| 2024incomplete | 4,806 | $100K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 6,636 | 6,177 | $320K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 16% | 4,098 | 3,365 | $122K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.1% | 1,126 | 1,029 | $54K |
| 85027 | 6.3% | 8,824 | 6,775 | $48K | |
| 80053 | Comprehensive metabolic panel | 4.1% | 4,057 | 3,528 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 703 | 653 | $22K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.5% | 397 | 101 | $19K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.2% | 295 | 81 | $17K |
| 59025 | Fetal non-stress test | 1.4% | 379 | 195 | $11K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.2% | 262 | 247 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 693 | 348 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 273 | 244 | $7K |
86 more codes
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 288 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 577 | $6K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 202 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 132 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 131 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 106 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 149 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 486 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,040 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 82 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 185 | $3K |
| 99285 | Emergency room visit (most serious) | <1% | 59 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 388 | $3K |
| 85007 | <1% | 2,426 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 121 | $3K |
| 83655 | <1% | 173 | $3K | |
| 81001 | <1% | 749 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 217 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 31 | $2K |
| 86592 | <1% | 361 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 15 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $1K |
| G0378 | Hospital observation service, per hour | <1% | 14 | $1K |
| 86885 | <1% | 162 | $1K | |
| 80061 | Lipid panel | <1% | 142 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 229 | $1K |
| 83690 | <1% | 164 | $968.08 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $965.42 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 73 | $951.68 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 25 | $937.29 |
| 84484 | <1% | 113 | $923.17 | |
| 87186 | <1% | 109 | $919.74 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 102 | $871.92 |
| 87077 | <1% | 113 | $759.55 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $736.19 |
| 82728 | <1% | 50 | $721.07 | |
| 86901 | <1% | 162 | $695.53 | |
| 88142 | <1% | 38 | $674.98 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,402 | $608.10 |
| 86900 | <1% | 161 | $571.88 | |
| 81025 | <1% | 54 | $467.63 | |
| 82552 | <1% | 45 | $452.80 | |
| 83874 | <1% | 44 | $431.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 79 | $430.95 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $400.85 |
| 87070 | <1% | 53 | $291.20 | |
| 84702 | <1% | 32 | $288.40 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 15 | $284.90 |
| 85610 | <1% | 90 | $273.45 | |
| 84439 | <1% | 19 | $273.06 | |
| Q3014 | Telehealth originating site facility fee | <1% | 24 | $237.11 |
| 83735 | <1% | 48 | $235.99 | |
| 87420 | <1% | 17 | $222.36 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $198.24 |
| 85730 | <1% | 49 | $194.24 | |
| 87340 | <1% | 12 | $176.33 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 131 | $172.22 |
| 82247 | <1% | 18 | $131.24 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 53 | $119.46 |
| 83880 | <1% | 15 | $116.24 | |
| 86762 | <1% | 12 | $108.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 48 | $98.83 |
| 80076 | <1% | 28 | $97.90 | |
| A0425 | Ground mileage, per statute mile | <1% | 76 | $91.17 |
| 83605 | <1% | 14 | $89.10 | |
| 85379 | <1% | 53 | $83.78 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 102 | $80.43 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 57 | $67.22 |
| 86140 | <1% | 59 | $59.95 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 31 | $57.92 |
| 85018 | <1% | 29 | $49.99 | |
| 82550 | <1% | 36 | $37.08 | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 13 | $35.85 |
| 85384 | <1% | 36 | $30.38 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 198 | $28.57 |
| 85014 | <1% | 16 | $27.36 | |
| 83615 | <1% | 36 | $23.48 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 29 | $12.53 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 46 | $11.90 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 81 | $9.91 |
| A9270 | Non-covered item or service | <1% | 41 | $6.63 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 101 | $0.52 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 14 | $0.00 |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 17 | $0.00 |
| C1752 | Catheter, hemodialysis/peritoneal, short-term | 0% | 20 | $0.00 |
| A0429 | Emergency ambulance ride, basic life support | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, BRIAN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Coffeyville Regional Medical Center INC | Coffeyville, KS | $2.55M |
| Coffeyville Regional Medical Center, INC. | Independence, KS | $641K |
| Coffeyville Regional Medical Center INC | Coffeyville, KS | $177K |
| Coffeyville Regional Medical Center, INC | Coffeyville, KS | $69K |
| Coffeyville Regional Medical Center INC | Coffeyville, KS | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.